Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Doublets Chemotherapy in Advanced Bladder Cancer
NCT00005086Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Aug 1999
- Primary completion
- Aug 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, methotrexate, gemcitabine, cisplatin in bladder cancer, sponsored by University of Chicago. Started Aug 1999; status: completed.
02
Drugs
docetaxelmethotrexategemcitabinecisplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00005086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005086.